Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.371,62
0,15%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ARYA Sciences Acquisition Corporation II (ARYBU) ARYA Sciences Acquisition Corporation II (ARYBU) Notizie

ARYBU

ARYA Sciences Acquisitio... (ARYBU)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARYBU
DataOraFonteTitoloSimboloCompagnia
29/06/202301:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
15/06/202322:37Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
14/06/202322:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
09/05/202301:04Edgar (US Regulatory)Amended Report of Proposed Sale of Securities (144/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
03/05/202322:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
28/04/202322:46Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
28/04/202322:12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
25/04/202319:38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
21/04/202323:24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
14/02/202323:53Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
09/02/202316:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
09/01/202314:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
21/11/202212:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
12/08/202212:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
10/05/202213:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
28/04/202222:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
01/03/202223:45Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
01/03/202222:41Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
10/11/202113:30Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
10/11/202112:54Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
30/08/202122:25Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
10/08/202116:34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
02/07/202123:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
25/11/202022:19Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
16/11/202022:52Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
28/10/202012:00GlobeNewswire Inc.Cerevel Therapeutics Debuts as Publicly Traded Neuroscience CompanyNASDAQ:ARYBUARYA Sciences Acquisition Corporation II
27/10/202021:34Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
26/10/202022:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
21/10/202018:34GlobeNewswire Inc.ARYA Sciences Acquisition Corp II Announces Extraordinary General Meeting Teleconference DetailsNASDAQ:ARYBUARYA Sciences Acquisition Corporation II
02/10/202023:20Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARYBU

La tua Cronologia

BIBX
SUIUSDT
SUI Network
EU
0005H
Goldman Sachs Group Inc ...
NASDAQ
COFS
ChoiceOne Financial Serv...
BTRX
WAXPUSDT
WAX Protocol Tokens
USOTC
ROIUF
Route1 (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network